BIOMAT Database Logo BIOMAT Database Logo

[Content of fibronectin in ascites--a method for differentiation of malignant and benign disease]. 1987

P Jönsson, and B Brodin, and P Jorpes, and B Lindberg

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.

Related Publications

P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
[Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
January 1991, Zeitschrift fur Gastroenterologie,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
November 1984, Gastroenterology,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Quantitative parameters measured by a new sonographic method for differentiation of benign and malignant breast disease.
July 1995, Investigative radiology,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Serum-ascites albumin concentration gradient and ascites fibronectin in the diagnosis of malignant ascites.
October 1992, Cancer,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Role of fibronectin in diagnosis of malignant ascites.
April 1997, The Journal of the Association of Physicians of India,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Differentiation of benign from malignant ascites by sonographic evaluation of gallbladder wall.
November 1985, Radiology,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Evaluation of fibronectin as a marker of malignant ascites.
January 1992, Journal of gastroenterology and hepatology,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Differentiation of benign versus malignant breast disease.
March 1999, Radiology,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Differentiation of benign from malignant induced ascites by measuring gallbladder wall thickness.
October 2011, Maedica,
P Jönsson, and B Brodin, and P Jorpes, and B Lindberg
Fibronectin concentration in ascites does not differentiate between malignant and nonmalignant ascites.
February 1988, Gastroenterology,
Copied contents to your clipboard!